Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: MacroRisk Analytics/EconomicInvestor
Provider: MacroRisk Analytics/EconomicInvestor
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sanofi SA Lifts FY 2012 Outlook-Reuters

Thursday, 25 Oct 2012 01:34am EDT 

Reuters reported that Sanofi SA said full-year 2012 earnings will decline less than expected, despite the loss of top-selling drugs previously protected by patents, after third-quarter results beat expectations. The French drugmaker said earnings could drop around 12% in 2012, compared with a previous forecast of 1between 12% and 15% , as emerging markets, a tight grip on costs and growth in diabetes and rare disease drugs limit the negative impact of cheap drug copies. 

Company Quote

-0.12 -0.15%
20 Aug 2014